TCTC Holdings LLC decreased its stake in Pfizer by 4.2% in Q3, selling 54,872 shares but still holding 1,253,887 shares valued at $31.95 million, making it their 22nd largest holding. Pfizer exceeded Q4 earnings expectations with $0.66 EPS on $17.56 billion revenue, and declared a $0.43 quarterly dividend, yielding 6.2%. Despite positive earnings, the company’s high payout ratio of 126.47% is noted.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
TCTC Holdings LLC Reduces Stock Holdings in Pfizer Inc. $PFE
TCTC Holdings LLC decreased its stake in Pfizer by 4.2% in Q3, selling 54,872 shares but still holding 1,253,887 shares valued at $31.95 million, making it their 22nd largest holding. Pfizer exceeded Q4 earnings expectations with $0.66 EPS on $17.56 billion revenue, and declared a $0.43 quarterly dividend, yielding 6.2%. Despite positive earnings, the company’s high payout ratio of 126.47% is noted.